Healthcare -
Biotechnology - NASDAQ - US
$ 489.49
2.02 %
$ 126 B
Market Cap
-237.62
P/E
VRTX - COST OF REVENUE
Cost of Revenue VRTX - Vertex Pharmaceuticals Incorporated
1.53 B
LAST VALUE
19.03%
2 YEAR CAGR
22.81%
5 YEAR CAGR
38.03%
10 YEAR CAGR